Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Shares: 2015-2016

  • Enanta Pharmaceuticals' Preferred Shares was N/A to $158,000 in Q2 2016 from the same period last year, while for Jun 2016 it was $158,000, marking a year-over-year change of. This contributed to the annual value of $163,000 for FY2015, which is N/A change from last year.
  • According to the latest figures from Q2 2016, Enanta Pharmaceuticals' Preferred Shares is $158,000, which was up 1.28% from $156,000 recorded in Q1 2016.
  • Enanta Pharmaceuticals' Preferred Shares' 5-year high stood at $163,000 during Q3 2015, with a 5-year trough of $156,000 in Q1 2016.
  • Its 2-year average for Preferred Shares is $159,000, with a median of $158,000 in 2016.